From Information to Innovation
The member companies of the IGES Group contribute to designing infrastructures: for healthcare, transport, housing and education. For more than 40 years we have delivered research and consulting services – analyses, expert opinions, studies, concepts and strategies – in Europe.
6,000
Projects
200
Employees
15
Companies
7
Countries
Business division
Public Infrastructures in Germany
Business division
IGES Group continues internationalisation and joins the athagoras Group
The IGES Group joined the athagoras Group in March 2025 in order to drive forward internationalisation and expertise in the healthcare sector in a consistent and future-oriented manner. » Details
Expert opinion on the calculation of capital costs for railway infrastructure
Bundesnetzagentur sets capital costs lower than DB Netz AG. » Details
IGES panel at Bio Europe Spring: independent commercialisation is becoming increasingly important for biotech start-ups
This is because more and more biotech companies are deciding not to out-license the drug they have developed, but to bring it onto the market themselves. » Details
Independent marketing instead of out-licensing? Panel discussion at Bio Europe Spring
This is because more and more biotech companies are deciding not to out-license the drug they have developed, but to bring it onto the market themselves. » Details
Update: new guide provides information on the European pricing and reimbursement system for innovative pharmaceutical products
Due to high demand, IGES experts have reissued the successful guide on the European reimbursement and pricing systems for pharmaceutical products. It also provides updated information on the harmonisation of the benefit assessment of new therapies at EU level. » Details
IGES founds new subsidiary in Italy: IGES Italy Pharma Consulting
The IGES Group has opened another location in Europe. With the founding of IGES Italy Pharma Consulting, the Group also established a presence in Italy at the beginning of the year. » Details
IGES
